HO-1, which repairs the dysfunction caused by acetaldehyde-induced hepatocellular carcinoma and reverses the rise in Nrf2, was stimulated by genistein and induced a decrease in Keap1 downstream, leading to the inhibition of liver cancer [67]. The gene discussed is NFE2L2; the disease is liver cancer.